Prime Therapeutics earns accreditation from the National Committee for Quality Assurance
Prime recognized for Utilization Management Accreditation
EAGAN, Minn., May 25, 2023 /PRNewswire/ -- Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 38 million members nationally, today announced it was accredited by the National Committee for Quality Assurance (NCQA) for Utilization Management. NCQA Utilization Management Accreditation is a quality assessment program that focuses on consumer protection and customer service improvement.
"We are honored to receive this accreditation in utilization management from NCQA which reinforces our dedication and commitment to an evidence-based utilization management program designed to improve patient outcomes," said Mostafa Kamal, president, Prime Therapeutics, and chief executive officer, Magellan Rx. "This achievement demonstrates our commitment to NCQA's high quality standards as we strive to reimagine pharmacy management to provide the same care we would want for our loved ones."
NCQA Utilization Management Accreditation focuses on consumer protection and improvement in service to customers. Standards recognize that organizations that apply for accreditation have open access networks and can improve service quality and utilize customized structures to meet purchaser needs. NCQA Utilization Management Accreditation reduces duplicative oversight and inefficient gathering of information by organizations.
"Achieving NCQA Utilization Management demonstrates that Prime Therapeutics has the systems, process and personnel in place to conduct utilization management in accordance with the strictest quality standards," said NCQA President Margaret E. O'Kane.
NCQA has reviewed and accredited Prime's Utilization Management functions only. For complete details on the scope of this review, visit www.ncqa.org.
About Prime Therapeutics + Magellan Rx
View original content:https://www.prnewswire.com/news-releases/prime-therapeutics-earns-accreditation-from-the-national-committee-for-quality-assurance-301834035.html
SOURCE Prime Therapeutics LLC